Found 0 matching trials
Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma
PHASE3Primary Objective:
To compare the efficacy of TACE vs. CyberKnife SBRT in ...
Location
Stanford University School of Medicine
TATE Versus TACE in Intermediate Stage HCC
PHASE2An open label randomized study to compare TATE versus TACE in patients with...
Location
University of California, Irvine
Clinical Efficacy of Transarterial Chemoembolization in Elderly Patients With Advanced Unresectable Colorectal Cancer
PHASE2We plan to conduct a prospective, two-arm, open-label phase β
‘ study to eval...
Location
Multiple Locations
HAIC+Lenvatinib+Tislelizumab vs D-TACE+Lenvatinib+Tislelizumab for Unresectable HCC
PHASE2Drug-eluting Bead-Transarterial chemoembolization (D-TACE) is the most wide...
Location
The Second Affiliated Hospital of Nanchang University
Chemoembolization, Irinotecan Bead, Second Line Chemotherapy Treatment of Unresectable Metastatic Colorectal Cancer
PHASE1The primary objective of this study is to evaluate the safety and efficacy ...
Location
University of Colorado Cancer Center
Value of Functional Magnetic Resonance Imaging of Hepatocellular Carcinoma After Transarterial Chemoembolization or Transarterial Radioembolization
N/AHepatocellular carcinoma (HCC) is one of the most common malignancies world...
Location
University Hospital Zurich
Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma
PHASE1To determine the efficacy and toxicity of TACE combined with SBRT...
Location
Stanford University School of Medicine
Safety and Efficacy of Radiation Plus TACE and Lenvatinib in Advanced HCC With PVTT
NAThis is a multicentri prospective cohort study to investigate the safety an...
Location
The First Affiliated Hospital of Sun Yat-sen University
Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone in Patients With Hepatocellular Carcinoma
PHASE2IMPACT-TACE is an investigator-initiated, prospective, multicenter, randomi...
Location
University Hospital Basel
FAD Subtype-Guided Combination Therapy for Unresectable Hepatocellular Carcinoma
PHASE2This study is a prospective, multicenter Phase II trial evaluating a person...
Location
Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School